early breast cancer
FDA Expands Indications for Verzenio in Patients With Breast Cancer
The FDA has expanded the indications for abemaciclib (Verzenio, Eli Lilly) in early and metastatic breast cancer, ...
MARCH 31, 2023
Keytruda Approved to Treat High-Risk, Early-Stage TNBC
The FDA approved pembrolizumab (Keytruda, Merck) for high-risk, early-stage triple-negative breast cancer (TNBC) in ...
AUGUST 9, 2021
Load more